Download PDF
Semin Neurol 2019; 39(05): 531-541
DOI: 10.1055/s-0039-1691749
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Laboratory Evaluation of Peripheral Neuropathy

K.H. Vincent Lau
1   Division of Neuromuscular Medicine, Department of Neurology, Boston Medical Center, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
22 October 2019 (online)

    Permissions and Reprints

Abstract

Peripheral neuropathy is a common neurological disorder, with high prevalence especially in the aged population. The general evaluative approach is to first identify the type of peripheral neuropathy prior to investigating for a possible underlying etiology, which is an increasingly important endeavor, as many causes of peripheral neuropathy are now recognized as treatable. To this end, laboratory testing plays an important adjunctive role to a detailed history and examination. This review will discuss possible diagnostic laboratory testing pathways for different types of peripheral neuropathy, with the goal of minimizing costs and false-positive results while maximizing the likelihood of identifying a potentially reversible etiology.

Keywords

peripheral neuropathy - laboratory testing - multiple myeloma
 

  • References

  • 1 England JD, Gronseth GS, Franklin G. , et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (02) 185-192
    CrossrefPubMedGoogle Scholar
  • 2 Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 2004; 17 (05) 309-318
    CrossrefPubMedGoogle Scholar
  • 3 Alothman S, Alenazi A, Waitman LR, LeMaster J, Kluding P. Neuropathy and other risk factors for lower extremity amputation in people with diabetes using a clinical data repository system. J Allied Health 2018; 47 (03) 217-221
    PubMedGoogle Scholar
  • 4 Bruce D, Hunter M, Peters K, Davis T, Davis W. Fear of falling is common in patients with type 2 diabetes and is associated with increased risk of falls. Age Ageing 2015; 44 (04) 687-690
    CrossrefPubMedGoogle Scholar
  • 5 Callaghan BC, Price RS, Chen KS, Feldman EL. The importance of rare subtypes in diagnosis and treatment of peripheral neuropathy: a review. JAMA Neurol 2015; 72 (12) 1510-1518
    CrossrefPubMedGoogle Scholar
  • 6 Barohn RJ. Approach to peripheral neuropathy and neuronopathy. Semin Neurol 1998; 18 (01) 7-18
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Doughty CT, Seyedsadjadi R. Approach to peripheral neuropathy for the primary care clinician. Am J Med 2018; 131 (09) 1010-1016
    CrossrefPubMedGoogle Scholar
  • 8 Rison RA, Beydoun SR. Paraproteinemic neuropathy: a practical review. BMC Neurol 2016; 16: 13
    CrossrefPubMedGoogle Scholar
  • 9 Callaghan B, McCammon R, Kerber K, Xu X, Langa KM, Feldman E. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med 2012; 172 (02) 127-132
    CrossrefPubMedGoogle Scholar
  • 10 Huan MC. Laboratory evaluation of peripheral neuropathy. Semin Neurol 2010; 30 (04) 337-349
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Levine TD, Saperstein DS. Laboratory evaluation of peripheral neuropathy. Neurol Clin 2013; 31 (02) 363-376
    CrossrefPubMedGoogle Scholar
  • 12 Willison HJ, Winer JB. Clinical evaluation and investigation of neuropathy. J Neurol Neurosurg Psychiatry 2003; 74 (Suppl. 02) ii3-ii8
    CrossrefPubMedGoogle Scholar
  • 13 Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1293-306
    PubMedGoogle Scholar
  • 14 Lubec D, Müllbacher W, Finsterer J, Mamoli B. Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases. Postgrad Med J 1999; 75 (890) 723-727
    CrossrefPubMedGoogle Scholar
  • 15 Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral neuropathy: differential diagnosis and management. Am Fam Physician 2010; 81 (07) 887-892
    PubMedGoogle Scholar
  • 16 Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001; 24 (09) 1229-1231
    CrossrefPubMedGoogle Scholar
  • 17 Harrington DJ. Laboratory assessment of vitamin B12 status. J Clin Pathol 2017; 70 (02) 168-173
    CrossrefPubMedGoogle Scholar
  • 18 Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management. Am Fam Physician 2017; 96 (06) 384-389
    PubMedGoogle Scholar
  • 19 Shandal V, Luo JJ. Clinical manifestations of isolated elevated homocysteine-induced peripheral neuropathy in adults. J Clin Neuromuscul Dis 2016; 17 (03) 106-109
    CrossrefPubMedGoogle Scholar
  • 20 Smith J, Raines G, Schneider HG. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum. Clin Chem Lab Med 2018; 56 (02) 256-263
    CrossrefPubMedGoogle Scholar
  • 21 Katzmann JA, Kyle RA, Benson J. , et al. Screening panels for detection of monoclonal gammopathies. Clin Chem 2009; 55 (08) 1517-1522
    CrossrefPubMedGoogle Scholar
  • 22 Reda H, Chin RL. Peripheral neuropathies of rheumatologic disease and gluten-related disorders. Semin Neurol 2014; 34 (04) 413-424
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Gabbai AA, Castelo A, Oliveira AS. HIV peripheral neuropathy. Handb Clin Neurol 2013; 115: 515-529
    PubMedGoogle Scholar
  • 24 Hehir II MK, Logigian EL. Infectious neuropathies. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1274-1292
    PubMedGoogle Scholar
  • 25 Ungprasert P, Matteson EL. Neurosarcoidosis. Rheum Dis Clin North Am 2017; 43 (04) 593-606
    CrossrefPubMedGoogle Scholar
  • 26 Jann S, Beretta S, Bramerio M, Defanti CA. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve 2001; 24 (09) 1197-1201
    CrossrefPubMedGoogle Scholar
  • 27 Mathis S, Magy L, Le Masson G. , et al. Value of nerve biopsy in the management of peripheral neuropathies. Expert Rev Neurother 2018; 18 (07) 589-602
    CrossrefPubMedGoogle Scholar
  • 28 Allen JA. Chronic demyelinating polyneuropathies. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1310-1331
    PubMedGoogle Scholar
  • 29 Minagar A. GALOP syndrome: a treatable immune-mediated late-age onset polyneuropathy with gait ataxia. South Med J 2004; 97 (04) 333-334
    CrossrefPubMedGoogle Scholar
  • 30 Nyboe Andersen N, Pasternak B, Andersson M, Nielsen NM, Jess T. Risk of demyelinating diseases in the central nervous system in patients with inflammatory bowel disease treated with tumor necrosis factor inhibitors. JAMA Intern Med 2015; 175 (12) 1990-1992
    CrossrefPubMedGoogle Scholar
  • 31 Illes Z, Blaabjerg M. Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies. Handb Clin Neurol 2017; 146: 125-138
    CrossrefPubMedGoogle Scholar
  • 32 Querol L, Siles AM, Alba-Rovira R. , et al. Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy. Sci Rep 2017; 7 (01) 14411
    CrossrefPubMedGoogle Scholar
  • 33 Querol L, Nogales-Gadea G, Rojas-Garcia R. , et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 2014; 82 (10) 879-886
    CrossrefPubMedGoogle Scholar
  • 34 Kuwahara M, Suzuki H, Samukawa M, Hamada Y, Takada K, Kusunoki S. Clinical features of CIDP with LM1-associated antibodies. J Neurol Neurosurg Psychiatry 2013; 84 (05) 573-575
    CrossrefPubMedGoogle Scholar
  • 35 Verschueren A. Immune-mediated neuropathies: indications and value of nerve biopsy. Rev Neurol (Paris) 2007; 163 Spec No 1: 3S58-3S60
    PubMedGoogle Scholar
  • 36 Galban-Horcajo F, Vlam L, Delmont E. , et al. The diagnostic utility of determining anti-GM1: GalC complex antibodies in multifocal motor neuropathy: a validation study. J Neuromuscul Dis 2015; 2 (02) 157-165
    PubMedGoogle Scholar
  • 37 Delmont E, Halstead S, Galban-Horcajo F, Yao D, Desnuelle C, Willison H. Improving the detection of IgM antibodies against glycolipids complexes of GM1 and galactocerebroside in multifocal motor neuropathy using glycoarray and ELISA assays. J Neuroimmunol 2015; 278: 159-161
    CrossrefPubMedGoogle Scholar
  • 38 Pestronk A, Chuquilin M, Choksi R. Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside. J Neurol Neurosurg Psychiatry 2010; 81 (07) 726-730
    CrossrefPubMedGoogle Scholar
  • 39 Nobile-Orazio E, Giannotta C, Musset L, Messina P, Léger JM. Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2014; 85 (07) 754-758
    CrossrefPubMedGoogle Scholar
  • 40 Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011; 69 (01) 22-33
    CrossrefPubMedGoogle Scholar
  • 41 GeneDx. Neurology Genetics. Available at: https://www.genedx.com/test-catalog/medical-specialty/neurology/ . Accessed May 9, 2019
    PubMed
  • 42 GeneDx. GeneDx Neurology Test Requisition Form. Available at: https://www.genedx.com/wp-content/uploads/crm_docs/67148-Neurology-Test-Req-var_final.pdf . Accessed August 20, 2018
    PubMedGoogle Scholar
  • 43 Dalakas MC. Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies. Ther Adv Neurol Disorder 2018; 11: 1756285617746640
    PubMedGoogle Scholar
  • 44 Kuijf ML, Eurelings M, Tio-Gillen AP. , et al. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology 2009; 73 (09) 688-695
    CrossrefPubMedGoogle Scholar
  • 45 Keddie S, D'Sa S, Foldes D, Carr AS, Reilly MM, Lunn MPT. POEMS neuropathy: optimising diagnosis and management. Pract Neurol 2018; 18 (04) 278-290
    CrossrefPubMedGoogle Scholar
  • 46 Verschueren A. Motor neuropathies and lower motor neuron syndromes. Rev Neurol (Paris) 2017; 173 (05) 320-325
    CrossrefPubMedGoogle Scholar
  • 47 Stojkovic T. Hereditary neuropathies: an update. Rev Neurol (Paris) 2016; 172 (12) 775-778
    CrossrefPubMedGoogle Scholar
  • 48 Zis P, Hadjivassiliou M, Sarrigiannis PG, Barker ASJE, Rao DG. Rapid neurophysiological screening for sensory ganglionopathy: a novel approach. Brain Behav 2017; 7 (12) e00880
    CrossrefPubMedGoogle Scholar
  • 49 Pereira PR, Viala K, Maisonobe T. , et al. Sjögren sensory neuronopathy (Sjögren ganglionopathy): long-term outcome and treatment response in a series of 13 cases. Medicine (Baltimore) 2016; 95 (19) e3632
    PubMedGoogle Scholar
  • 50 Zis P, Rao DG, Sarrigiannis PG. , et al. Transglutaminase 6 antibodies in gluten neuropathy. Dig Liver Dis 2017; 49 (11) 1196-1200
    CrossrefPubMedGoogle Scholar
  • 51 Antoine JC, Camdessanché JP. Paraneoplastic neuropathies. Curr Opin Neurol 2017; 30 (05) 513-520
    CrossrefPubMedGoogle Scholar
  • 52 Malek E, Doumiati H, Salameh JS. Pyridoxine-induced sensory ataxic ganglionopathy: a case report and literature review. Acta Neurol Belg 2018 . doi: 10.1007/s13760-018-0919-7
    PubMedGoogle Scholar
  • 53 Esiri MM, Morris CS, Millard PR. Sensory and sympathetic ganglia in HIV-1 infection: immunocytochemical demonstration of HIV-1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation. J Neurol Sci 1993; 114 (02) 178-187
    CrossrefPubMedGoogle Scholar
  • 54 Alix JJ, Alam T, Garrard K. , et al. Variable sensory nerve conduction parameters in late onset Friedreich ataxia. Muscle Nerve 2017; 55 (02) E7-E8
    CrossrefPubMedGoogle Scholar
  • 55 Gorson KC, Ropper AH. Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications. Muscle Nerve 2003; 28 (05) 553-560
    CrossrefPubMedGoogle Scholar
  • 56 Birnbaum J. Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 2010; 16 (05) 287-297
    CrossrefPubMedGoogle Scholar
  • 57 Guarner J. Human immunodeficiency virus: diagnostic approach. Semin Diagn Pathol 2017; 34 (04) 318-324
    CrossrefPubMedGoogle Scholar
  • 58 Wallace SE, Bird TD. Molecular genetic testing for hereditary ataxia: what every neurologist should know. Neurol Clin Pract 2018; 8 (01) 27-32
    CrossrefPubMedGoogle Scholar
  • 59 Gibbons CH. Small fiber neuropathies. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1398-1412
    PubMedGoogle Scholar
  • 60 Brouwer BA, Bakkers M, Hoeijmakers JG, Faber CG, Merkies IS. Improving assessment in small fiber neuropathy. J Peripher Nerv Syst 2015; 20 (03) 333-340
    CrossrefPubMedGoogle Scholar
  • 61 Treister R, O'Neil K, Downs HM, Oaklander AL. Validation of the composite autonomic symptom scale 31 (COMPASS-31) in patients with and without small fiber polyneuropathy. Eur J Neurol 2015; 22 (07) 1124-1130
    CrossrefPubMedGoogle Scholar
  • 62 Lauria G, Cornblath DR, Johansson O. , et al; European Federation of Neurological Societies. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 2005; 12 (10) 747-758
    CrossrefPubMedGoogle Scholar
  • 63 Seger S, Stritt M, Doppler K. , et al. A semi-automated method to assess intraepidermal nerve fibre density in human skin biopsies. Histopathology 2016; 68 (05) 657-665
    CrossrefPubMedGoogle Scholar
  • 64 Provitera V, Gibbons CH, Wendelschafer-Crabb G. , et al. The role of skin biopsy in differentiating small-fiber neuropathy from ganglionopathy. Eur J Neurol 2018; 25 (06) 848-853
    CrossrefPubMedGoogle Scholar
  • 65 Boruchow SA, Gibbons CH. Utility of skin biopsy in management of small fiber neuropathy. Muscle Nerve 2013; 48 (06) 877-882
    CrossrefPubMedGoogle Scholar
  • 66 Backonja MM, Attal N, Baron R. , et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013; 154 (09) 1807-1819
    CrossrefPubMedGoogle Scholar
  • 67 Siao P, Cros DP. Quantitative sensory testing. Phys Med Rehabil Clin N Am 2003; 14 (02) 261-286
    CrossrefPubMedGoogle Scholar
  • 68 Buchmann SJ, Penzlin AI, Kubasch ML, Illigens BM, Siepmann T. Assessment of sudomotor function. Clin Auton Res 2019; 29 (01) 41-53
    CrossrefPubMedGoogle Scholar
  • 69 Berger MJ, Kimpinski K. Test-retest reliability of quantitative sudomotor axon reflex testing. J Clin Neurophysiol 2013; 30 (03) 308-312
    CrossrefPubMedGoogle Scholar
  • 70 Rajan S, Campagnolo M, Callaghan B, Gibbons CH. Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function?. Clin Auton Res 2019; 29 (01) 31-39
    CrossrefPubMedGoogle Scholar
  • 71 Blackmore D, Siddiqi ZA. Diagnostic criteria for small fiber neuropathy. J Clin Neuromuscul Dis 2017; 18 (03) 125-131
    CrossrefPubMedGoogle Scholar
  • 72 Cygankiewicz I, Zareba W. Heart rate variability. Handb Clin Neurol 2013; 117: 379-393
    PubMedGoogle Scholar
  • 73 Mckeon A, Benarroch EE. Autoimmune autonomic disorders. Handb Clin Neurol 2016; 133: 405-416
    PubMedGoogle Scholar
  • 74 Yozu A, Haga N, Funato T, Owaki D, Chiba R, Ota J. Hereditary sensory and autonomic neuropathy types 4 and 5: review and proposal of a new rehabilitation method. Neurosci Res 2016; 104: 105-111
    CrossrefPubMedGoogle Scholar
  • 75 Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000; 48 (04) 624-631
    CrossrefPubMedGoogle Scholar
  • 76 Carod-Artal FJ. Neurological complications of Zika virus infection. Expert Rev Anti Infect Ther 2018; 16 (05) 399-410
    CrossrefPubMedGoogle Scholar
  • 77 Teener JW. Miller Fisher's syndrome. Semin Neurol 2012; 32 (05) 512-516
    Article in Thieme ConnectPubMedGoogle Scholar
  • 78 Taams NE, Notermans NC, Fokkink WR, Tio-Gillen AP, Huizinga R, Schreurs MW, Jacobs BC. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies. J Peripher Nerv Syst 2018; 23 (04) 227-234
    CrossrefPubMedGoogle Scholar
  • 79 Solomon T, Willison H. Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis 2003; 16 (05) 375-381
    CrossrefPubMedGoogle Scholar
  • 80 Leis AA, Stokic DS, Webb RM, Slavinski SA, Fratkin J. Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve 2003; 28 (03) 302-308
    CrossrefPubMedGoogle Scholar
  • 81 Fooks AR, Cliquet F, Finke S. , et al. Rabies. Nat Rev Dis Primers 2017; 3: 17091
    CrossrefPubMedGoogle Scholar
  • 82 Dürr S, Naïssengar S, Mindekem R. , et al. Rabies diagnosis for developing countries. PLoS Negl Trop Dis 2008; 2 (03) e206
    CrossrefPubMedGoogle Scholar
  • 83 Wu CL, Ro LS, Jung SM. , et al. Clinical presentation and electrophysiological findings of porphyric neuropathies: a follow-up study. Muscle Nerve 2015; 51 (03) 363-369
    CrossrefPubMedGoogle Scholar
  • 84 Woolf J, Marsden JT, Degg T. , et al. Best practice guidelines on first-line laboratory testing for porphyria. Ann Clin Biochem 2017; 54 (02) 188-198
    CrossrefPubMedGoogle Scholar
  • 85 Sommer C. Nerve and skin biopsy in neuropathies. Curr Opin Neurol 2018; 31 (05) 534-540
    CrossrefPubMedGoogle Scholar
  • 86 England JD, Gronseth GS, Franklin G. , et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (02) 177-184
    CrossrefPubMedGoogle Scholar
  • 87 Zhang YS, Sun AP, Chen L, Dong RF, Zhong YF, Zhang J. Nerve biopsy findings contribute to diagnosis of multiple mononeuropathy: 78% of findings support clinical diagnosis. Neural Regen Res 2015; 10 (01) 112-118
    CrossrefPubMedGoogle Scholar
  • 88 Levin SN, Lyons JL. Infections of the nervous system. Am J Med 2018; 131 (01) 25-32
    CrossrefPubMedGoogle Scholar
  • 89 Breda S, Richter HP, Schachenmayr W. [Incidence of biopsy-detectable amyloid deposits in the retinaculum flexorum and in the tenosynovial tissue in carpal tunnel syndrome]. Zentralbl Neurochir 1993; 54 (02) 72-76
    PubMedGoogle Scholar
  • 90 Tracy JA, Dyck PJ, Dyck PJ. Primary amyloidosis presenting as upper limb multiple mononeuropathies. Muscle Nerve 2010; 41 (05) 710-715
    CrossrefPubMedGoogle Scholar
  • 91 Galant NJ, Westermark P, Higaki JN, Chakrabartty A. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy. Clin Sci (Lond) 2017; 131 (05) 395-409
    CrossrefPubMedGoogle Scholar
  • 92 Shobha N, Taly AB, Sinha S, Venkatesh T. Radial neuropathy due to occupational lead exposure: phenotypic and electrophysiological characteristics of five patients. Ann Indian Acad Neurol 2009; 12 (02) 111-115
    CrossrefPubMedGoogle Scholar
  • 93 Dsouza HS, Dsouza SA, Menezes G, Thuppil V. Evaluation and treatment of wrist drop in a patient due to lead poisoning: case report. Ind Health 2009; 47 (06) 677-680
    CrossrefPubMedGoogle Scholar
  • 94 Verhagen WI, Gabreëls-Festen AA, van Wensen PJ. , et al. Hereditary neuropathy with liability to pressure palsies: a clinical, electroneurophysiological and morphological study. J Neurol Sci 1993; 116 (02) 176-184
    CrossrefPubMedGoogle Scholar
  • 95 Robert-Varvat F, Jousserand G, Bouhour F. , et al. Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: neurophysiological data and proposed electrodiagnostic criteria. Muscle Nerve 2018; 57 (02) 217-221
    CrossrefPubMedGoogle Scholar
  • 96 Park JE, Noh SJ, Oh M, Cho DY, Kim SY, Ki CS. Frequency of hereditary neuropathy with liability to pressure palsies (HNPP) due to 17p11.2 deletion in a Korean newborn population. Orphanet J Rare Dis 2018; 13 (01) 40
    CrossrefPubMedGoogle Scholar